ArticleInternational journal of molecular sciences2025
The HER2MtGx Metagene Score as a Reliable Tool to Select HER2 Breast Cancer Patients for Neoadjuvant Targeted Therapy.
Daniel Guimarães Tiezzi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.